Prof. Uwe Siebert, MD, MPH, MSc, ScD, Professor of Public Health, is the Chair of the Department of Public Health and Health Technology Assessment at UMIT - University for Health Sciences, Medical Informatics and Technology in Austria and the Director of the Division for HTA in the ONCOTYROL – Center for Personalized Cancer Medicine in Austria. He is also Adjunct Professor of Health Policy and Management at the Harvard School of Public Health and Director of the Program on Cardiovascular Research at the Institute for Technology Assessment and Department of Radiology at the Massachusetts General Hospital, Harvard Medical School, Boston. He has an adjunct teaching appointment at the School of Public Health and Epidemiology at the University of Munich.
After medical school, Prof. Siebert worked for several years as a physician in international public health projects in West-Africa, Brazil, and Germany. He then earned an MPH at the Munich School of Public Health, and completed an MSc in Epidemiology and an ScD in Health Policy and Management with a concentration in decision sciences at the Harvard School of Public Health. Before he started his faculty position at Harvard Medical School, he was the Director of the Bavarian Public Health Research and Coordinating Center at the University of Munich, Germany, and completed Visiting Scholarship at the Harvard Center for Risk Analysis. Since 2014, he teaches the Summer Course on ‘Decision Analysis in Clinical Research’ at the Harvard School of Public Health.
His research interests include applying evidence-based quantitative and translational methods from public health, epidemiology, comparative effectiveness research, outcomes research, economic evaluation and decision sciences in the framework of health technology assessments (HTA) as well as in the clinical context of routine health care. His current substantive research focuses on cancer, cardiovascular disease, diabetes, hepatitis C, HIV, inflammatory bowel disease, and neurological disorders. His methodological research is focused on evaluations of public health interventions, prevention and screening, diagnostic imaging procedures, personalized medicine, the development of causal decision models, and study designs controlling for cross-over and multiple-line treatments.
Prof. Siebert is a member of the Harvard Flagship Initiative in Comparative Effectiveness Research, a member of the Latin America Consortium Advisory Committee of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), a member of the ‘National HTA Strategy’ Expert Group of the Federal Ministry of Health in Austria, a member of the Directors Board of the German Competence Network Heart Failure, a member of the Oncology Advisory Council of the Federal Ministry of Health in Austria, a member of the Austrian Cochrane Collaboration Branch, and a member of several international Directors and Trustees Boards (Society of Medical Decision Making, German Network of EbM, German Association of Health Economics). He has served as Vice President of the Society of Medical Decision Making (SMDM), a member of the ISPOR Board of Directors, a member of the International Expert Committee Advising the Institute for Quality and Efficiency in Health Care (IQWiG) on the Methods for Economic Evaluations of Health Care Interventions, and a member of the Advisory Board of the Ludwig Boltzmann Institute for Health Technology Assessment in Austria. He is the Chairman of the Working Groups ‘Health Economics’ and ‘Medical Decision Making’ and Clinical Guideline Commissioner for the Association of the Scientific Medical Societies in Germany (AWMF) of the German Society for Medical Informatics, Biometry and Epidemiology (GMDS). He is Co-Chair of the ISPOR-SMDM Modeling Good Research Practices Task Force, Co-Chair of the ‘Issues in Methodology Section’ of the SMDM Policy Initiative, and a Leadership Member of the ISPOR Personalized Medicine Special Interest Group.